Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.29B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$937M |
| 3 |
iShares Floating Rate Bond ETF
FLOT
|
+$662M |
| 4 |
iShares MSCI United Kingdom ETF
EWU
|
+$615M |
| 5 |
iShares MSCI EAFE Value ETF
EFV
|
+$541M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$1.06B |
| 2 |
Vanguard Total International Stock ETF
VXUS
|
+$717M |
| 3 |
Vanguard Total International Bond ETF
BNDX
|
+$633M |
| 4 |
SPDR Gold Trust
GLD
|
+$617M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$512M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.47% |
| 2 | Consumer Discretionary | 2.1% |
| 3 | Financials | 1.38% |
| 4 | Communication Services | 1.28% |
| 5 | Healthcare | 1.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRTA
8026
Strata Critical Medical Inc
SRTA
$533M
| $101K | ﹤0.01% |
29,880
+29
| +0.1% | +$118 |
|
8027
ALX Oncology
ALXO
$267M
| $101K | ﹤0.01% |
+22,273
| New | +$169K |
|
|
UNIT
8028
PUT
Uniti Group
UNIT
$2.25B
| $100K | ﹤0.01% |
+28,300
| New | +$150K |
|
8029
Quad
QUAD
$502M
| $100K | ﹤0.01% |
+23,416
| New | +$103K |
|
|
TIGR
8030
UP Fintech Holding
TIGR
$849M
| $100K | ﹤0.01% |
30,149
+1,365
| +5% | +$5.04K |
|
|
PRTK
8031
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $100K | ﹤0.01% |
39,518
+22,633
| +134% | +$44.7K |
|
|
CLLS
8032
Cellectis
CLLS
$291M
| $99.8K | ﹤0.01% |
50,522
-160,945
| -76% | -$403K |
|
|
MOLN
8033
Molecular Partners
MOLN
$155M
| $99.8K | ﹤0.01% |
16,816
-157
| -0.9% | -$1.01K |
|
8034
PUT
Denison Mines
DNN
$3B
| $99.4K | ﹤0.01% |
91,400
-90,100
| -50% | -$111K |
|
|
VAXX
8035
DELISTED
Vaxxinity, Inc. Class A Common Stock
VAXX
| $99.3K | ﹤0.01% |
+43,730
| New | +$111K |
|
8036
NGL Energy Partners
NGL
$2.13B
| $99.1K | ﹤0.01% |
34,173
+15,818
| +86% | +$37.3K |
|
8037
Hyliion Holdings
HYLN
$699M
| $99K | ﹤0.01% |
50,025
+6,638
| +15% | +$18.5K |
|
8038
Custom Truck One Source
CTOS
$2.42B
| $98.9K | ﹤0.01% |
+14,571
| New | +$101K |
|
8039
ProShares UltraShort Materials
SMN
$3.77M
| $98.9K | ﹤0.01% |
+2,614
| New | +$100K |
|
8040
Stagwell
STGW
$2.27B
| $98.2K | ﹤0.01% |
+13,239
| New | +$92.5K |
|
8041
Mitek Systems
MITK
$836M
| $98.2K | ﹤0.01% |
10,243
-18,185
| -64% | -$174K |
|
8042
Greenlight Captial
GLRE
$503M
| $97.9K | ﹤0.01% |
+10,424
| New | +$98.4K |
|
8043
Lands' End
LE
$402M
| $97.8K | ﹤0.01% |
+10,057
| New | +$84.2K |
|
|
MCOM
8044
DELISTED
micromobility.com Inc. Class A Common stock
MCOM
| $97.1K | ﹤0.01% |
+177
| New | +$217K |
|
8045
Interface
TILE
$2.24B
| $97.1K | ﹤0.01% |
11,953
-3,449
| -22% | -$33.9K |
|
8046
Empire State Realty Trust
ESRT
$802M
| $97K | ﹤0.01% |
14,940
-622
| -4% | -$4.56K |
|
8047
SKYX Platforms
SKYX
$165M
| $96.7K | ﹤0.01% |
+27,943
| New | +$92K |
|
|
8048
CALL
Denison Mines
DNN
$3B
| $96.6K | ﹤0.01% |
88,800
-1,455,700
| -94% | -$1.8M |
|
8049
Cue Biopharma
CUE
$119M
| $96.3K | ﹤0.01% |
+899
| New | +$85.7K |
|
8050
Monte Rosa Therapeutics
GLUE
$1.34B
| $96.2K | ﹤0.01% |
+12,349
| New | +$85.9K |
|
Similar funds
Jane Street's Q1 2023 Portfolio in Review
As of Q1 2023, Jane Street held 10,675 positions worth $244B, up 13% from $216B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Jane Street's Q1 2023 filing shows 1,657 new, 3,180 increased, 3,974 reduced and 1,760 closed positions. Its largest new stake was iShares MSCI EAFE Value ETF: 11,182,830 shares worth $543M. The largest sale was iShares Core MSCI Emerging Markets ETF, an estimated $1.06B.
By sector, the portfolio is most concentrated in Technology at 2.5% of assets, up from 2.4% a quarter earlier, followed by Consumer Discretionary and Financials.
- Jane Street's largest Q1 2023 buy was iShares MSCI EAFE Value ETF: 11,182,830 shares worth $543M.
- Jane Street added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q1 2023, an estimated $1.29B increase.
- Jane Street's biggest Q1 2023 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $1.06B.
- Jane Street fully exited State Street SPDR Bloomberg Convertible Securities ETF in Q1 2023, selling an estimated $119M.
- Jane Street's ten largest holdings make up 36% of its $244B portfolio in Q1 2023.
- Jane Street opened 1,657 new positions and closed 1,760 in Q1 2023.
- Jane Street's portfolio value rose 13% quarter-over-quarter to $244B.
Based on Jane Street's 13F filing for Q1 2023, filed 16 May 2023.